Drug application
APREPITANT (APREPITANT)
Drugs@FDA ANDA 216976 · MYLAN PHARMACEUTICALS INC
Key facts
| Drug name | APREPITANT |
|---|---|
| Active ingredients | APREPITANT |
| Application type | ANDA |
| Application number | 216976 |
| Company | MYLAN PHARMACEUTICALS INC |
| Dosage forms | INJECTION, EMULSION |
| Strength | 130MG/18ML |
| Marketing status | None (Tentative Approval) |
| Reference listed drug | No |
| Latest submission status date | Nov 17, 2025 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.